Gil J. van Lunsen is Director at ARRAY BIOPHARMA INC (ARRY). They have made 16 open-market trades across 3 companies since 2007, most recently 2022-03-04.
CIK 0001205014
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
3 open-market purchases totalling $97K since 2008, against 13 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ARRY | SELL | 2018-09-19 | 2018-09-21 | $14.76 | $266K | +33.9% | +23.6% | +23.6% |
| ARRY | SELL | 2018-08-15 | 2018-08-17 | $13.92 | $299K | +33.9% | +23.6% | +23.6% |
| ARRY | SELL | 2018-07-18 | 2018-07-19 | $16.56 | $356K | +33.9% | +23.6% | +23.6% |
| ARRY | SELL | 2018-06-20 | 2018-06-21 | $19.08 | $820K | +33.9% | +23.6% | +23.6% |
| ARRY | SELL | 2018-05-16 | 2018-05-17 | $15.36 | $330K | +33.9% | +23.6% | +23.6% |
| ARRY | SELL | 2018-04-18 | 2018-04-18 | $15.19 | $327K | +33.9% | +23.6% | +23.6% |
| ARRY | SELL | 2018-03-21 | 2018-03-21 | $16.76 | $721K | +33.9% | +23.6% | +23.6% |
| ARRY | SELL | 2018-02-21 | 2018-02-23 | $17.16 | $369K | +33.9% | +23.6% | +23.6% |
| ARRY | SELL | 2018-01-17 | 2018-01-17 | $12.94 | $278K | +33.9% | +23.6% | +23.6% |
| ARRY | SELL | 2017-09-29 | 2017-09-29 | $12.36 | $987K | +33.9% | +23.6% | +23.6% |
| MTSI | SELL | 2017-05-23 | 2017-05-25 | $60.01 | $120K | -2.7% | +0.9% | -30.2% |
| MTSI | SELL · 10b5-1 | 2017-04-11 | 2017-04-13 | $50.85 | $49K | -1.2% | +0.7% | +18.7% |
| MTSI | SELL · 10b5-1 | 2017-03-14 | 2017-03-16 | $46.05 | $46K | -0.5% | +9.9% | +20.8% |
| MTSI | SELL · 10b5-1 | 2017-02-14 | 2017-02-16 | $45.47 | $45K | -1.0% | -0.2% | +14.5% |
| MTSI | SELL · 10b5-1 | 2017-01-17 | 2017-01-19 | $46.83 | $47K | -0.1% | +5.0% | +6.5% |
| MTSI | SELL · 10b5-1 | 2016-12-13 | 2016-12-15 | $49.13 | $49K | -5.4% | -5.9% | -7.6% |
| MTSI | SELL · 10b5-1 | 2016-11-15 | 2016-11-17 | $40.69 | $41K | +7.1% | +4.6% | +0.9% |
| MTSI | SELL · 10b5-1 | 2016-10-11 | 2016-10-13 | $42.17 | $42K | -2.2% | +2.9% | +16.4% |
| MTSI | SELL · 10b5-1 | 2016-09-13 | 2016-09-15 | $41.06 | $41K | -4.0% | -8.9% | +12.8% |
| MTSI | SELL · 10b5-1 | 2016-08-22 | 2016-08-24 | $40.00 | $40K | +3.9% | -4.3% | +7.9% |
| MTSI | SELL | 2016-07-28 | 2016-08-01 | $40.00 | $80K | -2.5% | +3.2% | -7.9% |
| OKS | BUY | 2010-02-26 | 2010-03-02 | $60.44 | $18K | -15.9% | +2.1% | +2.1% |
| OKS | BUY | 2009-06-23 | 2009-06-25 | $43.26 | $52K | -15.9% | +2.1% | +2.1% |
| OKS | BUY | 2008-11-10 | 2008-11-12 | $54.01 | $27K | -15.9% | +2.1% | +2.1% |
| ARRY | SELL | 2007-08-09 | 2007-08-13 | $11.47 | $138K | +33.9% | +23.6% | +23.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.